Finch Therapeutics Group, Inc. — 10-Q Filings
11 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Finch Therapeutics Group, Inc. (FNCH), sorted by most recent first. Each row links to the full filing on EdgarLookup. Finch Therapeutics Group, Inc. has filed 11 10-Q documents with the SEC since 2018. To view all SEC filings by Finch Therapeutics Group, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
15-12G
25
3
4
4/A
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
S-8 POS
SC 13D
SC 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0000950170-24-096246 | Aug 13, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-057912 | May 10, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-060651 | Nov 8, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-040924 | Aug 10, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-020080 | May 10, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-024152 | Nov 10, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-016637 | Aug 11, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-009936 | May 16, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0000950170-21-004159 | Nov 10, 2021 | Sep 30, 2021 |
| 10-Q | Q2 2021 10-Q | 0001564590-21-043094 | Aug 10, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-027625 | May 13, 2021 | Mar 31, 2021 |